How fast is your brain ageing? Proteins in blood offer clues
On Dec. 9, 2024, neurologists at Fudan University in Shanghai, China have identified 13 proteins in the blood…
TGen-ASU study revealed lasting effects of common herbicide on brain health
On Dec. 4, 2024 a study led by researchers from TGen and Arizona State University showed that pre-clinical models exposed…
AARP and Leading Research Organizations Announced Risk Factors of Dementia Research Findings
On Nov. 15, 2024, the AARP, the Alzheimer’s Disease Data Initiative (AD Data Initiative), and the Institute for…
Alzheimer’s and alcohol use disorder share similar gene expression patterns
On Nov. 5, 2024, Scripps research scientists reported they have shown that Alzheimer’s and alcohol use disorder (AUD)…
Neuroscientists revealed Integrated multimodal cell atlas of Alzheimer’s disease
On Oct, 14, 2024, a team of researchers from the Allen Institute of Brain Science and the University…
Risk of Dementia Diagnosis After Injurious Falls in Older Adults
On Sept. 30, 2024, a research team reported that emerging evidence suggested that mild cognitive impairment, which is…
Biology | Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Neurology | Non-Profit Research | Therapeutics
landmark UT Health San Antonio study found genetic risk-factor overlap between Alzheimer’s disease, and dementias
On Sept. 17, 2024, in landmark research, scientists at The University of Texas Health Science Center at San…
“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
Diagnostics | Disease | Life Science News | Medical Device | Nanotechnology | Neurology | Non-Profit Research | Therapeutics
Imaging technique shows new details of peptide structures
On Apr. 26, 2024, engineers at Washington University in St. Louis announced a new imaging technique that give…
FDA approved first drug to treat agitation symptoms associated with dementia due to Alzheimer’s disease
On May 11, 2023, the U.S. Food and Drug Administration (FDA) announced the supplemental approval of Otsuka Pharmaceutical…
A 19-Year-Old Adolescent with Probable Alzheimer’s Disease
On Jan. 31, 2023, a team of researchers led by the Innovation Center for Neurological Disorders and Department…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
Stanford University launched $75 million brain disease initiative
On Apr. 22, 2022, Stanford University announced it was awarded a $75 million gift from Nike co-founder Phil…
Blood test for Alzheimer’s highly accurate in large, international study
On Feb. 22, 2022, Washington University in St. Louis announced that a blood test developed at the University’s…
NIH unveiled new online tool to improve Alzheimer’s clinical trials recruitment
On Jul. 29, 2021, the National Institutes of Health announced it had launched a new online research tool…
Eisai and Biogen announced FDA granted Breakthrough Therapy Designation for Lecanemab for treatment of Alzheimer’s disease
On Jun. 23, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | NIH | Therapeutics
Seattle researchers teamed up to build hi-res brain map of Alzheimer’s disease
On Jun. 25, 2020, the Allen Institute announced a new a new $40.5 million collaborative research center in…
Alzheimerﾒs trial screening data links high amyloid levels with early stage disease
On Apr. 6, 2020, the first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) study…
Research on brain structure highlighted cells linked to Alzheimer’s and autism
On Mar. 16, 2020, new insights into the architecture of the brain were revealed by scientists at the…
Biotechnology | Diagnostics | Life Science News | Neurology | NIH | Non-Profit Research | Therapeutics
Emory Selected to lead international drug discovery center for Alzheimer’s
On Oct 1, 2019, the National Institute on Aging (NIA) announced it had awarded approximately $37 million over…
Penn researcher Virginia MY Lee, PhD, received $3 million Breakthrough Prize
On Sept. 5, 2019, Penn Professor Virginia M.Y. Lee, PhD received the Breakthrough Prize in Life Sciences, in…
A UCLA-led research team identified genetic processes involved in the neurodegeneration that occurs in dementiaﾠ
On Dec 3, 2018, a University of California, Los Angeles (UCLA) led research team announced they had identified…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
Emory renamed its Alzheimer’s Disease Research Center the Goizueta Alzheimer’s Disease Research Center
On Aug. 24, 2018, Emory Universityﾒs Alzheimer’s Disease Research Center was renamed the Goizueta Alzheimer’s Disease Research Center,…
Canada Foundation awarded $6 million for Innovation Metabolomics Innovation Centre at the University of Alberta
On Jan. 9, 2017, the Canada Foundation for Innovation (CFI) awarded $6 million for Canada’s national metabolomics laboratory,…
The Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech was founded
In 2016, the Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech was founded with a $1 billion…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
The Kavli Foundation awarded $20 million to establish the Kavli Neural Systems Institute at The University of California, San Francisco
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Institute for Fundamental…
Biotechnology | Diagnostics | Life Science News | Medical Device | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics
Keck School of Medicine of USC established USC Alzheimer’s Therapeutic Research Institute
On Jun. 26, 2015, The Keck School of Medicine announced it had established the University of Southern California…
Canadian diamond pioneer Charles Fipke donated $9.1 million for Alzheimer’s research at UBC
On Sept. 30, 2014, Canadian diamond pioneer Charles Fipke donated $9.1 million for Alzheimer’s research at the University…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Therapeutics | Women's Health
Stanford Medicine researchers found that a gene variant puts women at higher risk of Alzheimer’s than it does men
On Apr. 14, 2014, Stanford Medicine researchers announced a study that found a gene variant puts women at…
Largest international study of Alzheimer’s genes was published
On Oct. 28, 2013, Columbia University Medical Center announced publication of a Meta-analysis of 74,046 individuals that identified…
Roskamp Institute selected for funding by European Commission for a large-scale clinical trial on Nilvadipine
On May 25, 2011, the Roskamp Institute and an international research consortium led by Trinity College Dublin, were…